ATP

DSV is a transport and logistics company based in Hedehusene, Denmark, that offers a wide range of transportation services globally, including road, air, sea, and train logistics. Founded in 1976, the company has primarily focused on its European trucking network, as well as airfreight and sea freight forwarding divisions. DSV has experienced significant growth, largely through acquisitions, including the notable purchase of GIL in 2021, which enhanced its revenue diversity and expanded its presence in key regions like the Middle East. This strategic growth has positioned DSV among the top three largest third-party logistics firms worldwide.

MedTrace Pharma A/S, founded in 2015 and headquartered in Kongens Lyngby, Denmark, specializes in medical technology focused on improving positron emission tomography (PET) imaging. The company has developed an automated system, known as MT-100, which facilitates the bedside production and infusion of radioactive water, specifically 15O-water, into patients during PET scans. This innovative approach enhances the sensitivity of imaging results and significantly increases patient throughput. Complementing the MT-100 system is aQuant, an analytical software platform designed to interpret the PET scan data generated from the use of 15O-water. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace Pharma aims to advance clinical practices in diagnostic imaging through its cutting-edge technology.

Veo Technologies ApS specializes in developing video technology that enables the automatic recording and analysis of football matches without the need for a cameraman. Founded in 2015 and based in Copenhagen, Denmark, the company provides a solution that allows clubs, players, coaches, scouts, families, and fans to capture and share high-quality sports footage easily. Veo's platform uses two action cameras that automatically track player and ball movement, producing complete video recordings of matches. This technology eliminates the need for manual video editing, making it accessible and affordable for football clubs of all sizes to stream and review their games.

MedTrace Pharma A/S, founded in 2015 and headquartered in Kongens Lyngby, Denmark, specializes in medical technology focused on improving positron emission tomography (PET) imaging. The company has developed an automated system, known as MT-100, which facilitates the bedside production and infusion of radioactive water, specifically 15O-water, into patients during PET scans. This innovative approach enhances the sensitivity of imaging results and significantly increases patient throughput. Complementing the MT-100 system is aQuant, an analytical software platform designed to interpret the PET scan data generated from the use of 15O-water. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace Pharma aims to advance clinical practices in diagnostic imaging through its cutting-edge technology.

Visiopharm A/S is a Danish company specializing in AI-based image analysis and tissue mining tools for the pathology industry, founded in 2001. The company develops digital pathology solutions that include the Oncotopix scanner for capturing digital images of slides, and a suite of AI-based applications designed for diagnostic and clinical research. Among its offerings are advanced image analysis software, the Visiopharm Viewer for displaying images, the AI Phenotyping module for automating analysis workflows, the Tissuealign module for aligning digitalized serial sections, and VirtualDoubleStain for automating stroma separation. Visiopharm's solutions are widely adopted by leading biopharmaceutical companies, academic medical centers, and research institutes globally, with over 500 licenses in more than 30 countries. The company operates through a network of distributors across Europe, North America, Latin America, Asia, and Australia, and maintains its headquarters in Horsholm, Denmark, with additional offices in Germany, Sweden, the United Kingdom, and the United States.

Visiopharm A/S is a Danish company specializing in AI-based image analysis and tissue mining tools for the pathology industry, founded in 2001. The company develops digital pathology solutions that include the Oncotopix scanner for capturing digital images of slides, and a suite of AI-based applications designed for diagnostic and clinical research. Among its offerings are advanced image analysis software, the Visiopharm Viewer for displaying images, the AI Phenotyping module for automating analysis workflows, the Tissuealign module for aligning digitalized serial sections, and VirtualDoubleStain for automating stroma separation. Visiopharm's solutions are widely adopted by leading biopharmaceutical companies, academic medical centers, and research institutes globally, with over 500 licenses in more than 30 countries. The company operates through a network of distributors across Europe, North America, Latin America, Asia, and Australia, and maintains its headquarters in Horsholm, Denmark, with additional offices in Germany, Sweden, the United Kingdom, and the United States.